Last reviewed · How we verify

Tamsulosin - 3 days

Hackensack Meridian Health · Phase 1 active Small molecule Quality 0/100

Tamsulosin - 3 days is a Small molecule drug developed by Hackensack Meridian Health. It is currently in Phase 1 development.

At a glance

Generic nameTamsulosin - 3 days
SponsorHackensack Meridian Health
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Tamsulosin - 3 days

What is Tamsulosin - 3 days?

Tamsulosin - 3 days is a Small molecule drug developed by Hackensack Meridian Health.

Who makes Tamsulosin - 3 days?

Tamsulosin - 3 days is developed by Hackensack Meridian Health (see full Hackensack Meridian Health pipeline at /company/hackensack-meridian-health).

What development phase is Tamsulosin - 3 days in?

Tamsulosin - 3 days is in Phase 1.

What are the side effects of Tamsulosin - 3 days?

Common side effects of Tamsulosin - 3 days include Dry mouth, Dizziness/lightheadedness, Constipation.

Related